Clinical trials
Completed Myocardial Infarction trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
66 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 3 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 3 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 6 |
| 2011 | 9 |
| 2012 | 3 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 66 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 4 |
| Foundation of Cardiovascular Research and Education Enschede | 3 |
| VieCuri Medical Centre | 3 |
| Cytori Therapeutics | 2 |
| Hoffmann-La Roche | 2 |
| Janssen Research & Development, LLC | 2 |
| Leiden University Medical Center | 2 |
| Maasstad Hospital | 2 |
| Maastricht University Medical Center | 2 |
| Miracor Medical SA | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myocardial Infarction | 66 |
| Coronary Artery Disease | 20 |
| Acute Coronary Syndrome | 18 |
| Cardiovascular Diseases | 12 |
| Myocardial Ischemia | 12 |
| Angina, Unstable | 10 |
| Heart Diseases | 10 |
| ST Elevation Myocardial Infarction | 8 |
| Stroke | 8 |
| Angina Pectoris | 5 |
Trials
Showing 1 to 25 of 66. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.